NPPA issues clarification on discontinues the sale of coronary stent in Indian Market

Feb 26, 2018 | by Avantis RegTech Legal Research Team

A |  A

National Pharmaceutical Pricing Authority (NPPA) vide office memorandum dated February 21, 2018has decided not to disallow any application submitted forwithdrawal ofstents, from the market by the stent manufacturer/importers.

Anymanufacturerintending to discontinueproduction or import ofany Coronary Stentshallfurnish information to the NPPA, in respect ofdiscontinuation ofproduction and/orimportin Form-IV ofSchedule-II of the DPCO, 2013 atleast 6 months priorto the intended date of discontinuation as prescribed under paragraph 21(2) ofthe DPCO, 2013 andfollow the ceiling price in such manner andtillsuch a time prescribed bythe Government.

[F.No.20 (8)/2018/Div-III/NPPA/]




Related Updates

Alternate Text

Get updates on the go on RuleZbook Mobile App.